Everbright executing OTC swaps for Chinese insurers
After being cleared to conduct over-the-counter equity derivatives, the securities firm seeks to target insurers initially. It sees room for growth in this area amid CSRC liberalisation.
Everbright Securities became one of the first companies allowed to conduct over-the-counter (OTC) equity swaps in China this month – a sign of the rising role such firms are playing in the development of the country’s capital markets.
Everbright’s 15-strong global markets division, led by managing director James Yang in Shanghai, is executing OTC derivatives with several Chinese insurers, helping them to hedge their portfolio allocation risk.
It comes after the China Insurance R…
Please sign in or register
for free access to 1 article per month from AsianInvestor’s content and archives of over 16,000 articles.
¬ Haymarket Media Limited. All rights reserved.